Michigan State University researchers have identified how ovarian cancer cells become resistant to chemotherapy and ...

Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer. Discovery of a subset of high-risk progenitor cells that reside in fallopian tube ...

A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond better to treatment than others. Tumors positive for a molecule called MHC class II are linked to ...

Scientists uncover the ovarian cancer cause behind drug resistance and immune therapy failure - here's what the latest 2026 ...

Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the disease spreads throughout the abdomen. Until now, scientists have never fully ...

Bio, Inc. ( a clinical-stage biotechnology company developing next-generation T-cell engaging antibodies (TCEs), today announced dosing of the first patient in a Phase 1 clinical trial evaluating NTB ...

Researchers found lowering TPPP3 may make ovarian cancer more sensitive to cisplatin, improving chemotherapy’s effectiveness.

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer. Research has shed light on how a new type of antibody treatment reactivates ...

Reston, VA (July 24, 2025)—A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold ...

Researchers at Karolinska Institutet have uncovered a unique ability of a special subtype of natural killer cells in the immune system, called adaptive NK cells, to remember ovarian tumors and ...